34 28 36

10 20

28
Cover Story 10
Dear friends and readers, I hope you would have enjoyed reading our previous issue.
Once again, I am delighted to bring to you the January 2020 edition of the Microbioz
India Health edition, supported by the cover story entitled “Purification and
Maintenance of Cardiomyocytes” an editorial submitted by AMSBIO.AMSBIO has
introduced human recombinant iMatrix Laminin 211 fragment for the purification and
maintenance of cardiomyocytes in culture.
Featured article 16
Added to this, the current edition has a special featured guest article entitled
“Effectiveness of healing with Beej Mantra” authored by Dr Arti & Dr Gaurav Shukla
along with Dr. Tarini and Dr. Neelam Vats. Beej Mantra is the shortest form of a Mantra
just like a Beej (seed) which when sown grows into a tree. When recited together these
Beej Mantras give humans lot of positive energy. They are the vibrations, and represent
the "call" of the soul. It is a belief that when the universe was created then the sounds
produced during the cosmic evolution were basically the Beej mantras.
Product Launches 28
The edition also covers recent Healthcare news articles and product launches collected
from worldwide sources to update the readers with the current trends in the industry
Indian Non-Profit YRGCARE Selects NetSuite to 18
Support its Mission to Save More Live
YRGCARE, an Indian non-profit that provides clinical care to
individuals diagnosed with HIV and other infectious diseases,
has selected Oracle NetSuite to support its mission to save more
lives.
Zeiss Introduces Four Axiocam Models for Light 28
Microscopy Applications
Zeiss, Oberkochen, Germany, has introduced four new high-
quality complementary metal oxide semiconductor (CMOS)
cameras to support digital imaging in light microscopy.
FDA Clears Lumipulse G Whole PTH Assay 28
Fujirebio Diagnostics, Malvern, Pa, has received FDA
clearance for use of its new Lumipulse G whole PTH assay on
the company’s Lumipulse G1200 immunoassay platform.

Microbioz India, January 2020 06

ear friends and readers, I hope you would have enjoyed reading
our previous issue. Once again, I am delighted to bring to you
the January 2020 edition of the Microbioz India Health edition,
supported by the cover story entitled “Purification and
Maintenance of Cardiomyocytes” an editorial submitted by
AMSBIO.
AMSBIO has introduced human recombinant iMatrix Laminin
211 fragment for the purification and maintenance of
cardiomyocytes in culture.
The Laminin family of glycoproteins are an integral part of the
structural scaffolding in almost every tissue of an organism.
They are secreted and incorporated into cell-associated
extracellular matrices. Laminin is vital for the maintenance and
survival of tissues. Defective Laminins can cause muscles to
form improperly, leading to a form of muscular dystrophy,
lethal skin blistering disease and defects of the kidney filter.
Added to this, the current edition has a special featured guest
article entitled “Effectiveness of healing with Beej Mantra”
authored by Dr Arti & Dr Gaurav Shukla along with Dr. Tarini and
Dr. Neelam Vats.Beej Mantra is the shortest form of a Mantra
just like a Beej (seed) which when sown grows into a tree. When
recited together these Beej Mantras give humans lot of positive
energy. They are the vibrations, and represent the "call" of the
soul. It is a belief that when the universe was created then the
sounds produced during the cosmic evolution were basically
the Beej mantras. After attaining knowledge of the Beej
Mantras and understanding its connections with Mind, Body &
Soul, the individual can use subtle energy to heal physical and
psychological ailments.
We have the latest market research news and insightful
product launches inside, collected from worldwide sources to
keep you updated with what is going on in the industry.
Dear friends and readers, I hope you find some value in the
magazine. Also, I would like to thanks you for being together in
this beautiful journey so far. We would love to have your
valuable feedback and suggestions as they help us to come up
with better content each time. For any further valuable
addition, please write to us at editor@microbiozindia.com.
Cover Story

Purification and Maintenance

of Cardiomyocytes
AMSBIO has introduced human recombinant iMatrix Laminin 211
fragment for the purification and maintenance of cardiomyocytes in
culture.

T
he Laminin family
of glycoproteins are
an integral part of
the structural
scaffolding in
almost every tissue
of an organism.
They are secreted
and incorporated
into cell-associated extracellular
matrices. Laminin is vital for the
maintenance and survival of
tissues. Defective Laminins can
cause muscles to form
improperly, leading to a form of
muscular dystrophy, lethal skin
blistering disease and defects of
the kidney filter.

Laminin 211 is known to support

the growth, survival, and
differentiation of a wide range of
tissue-specific cell types,
including cardiac cells, skeletal muscle cells and
motor neurons. As one of the main isoforms 211 fulfils this purpose through its binding
present in adult muscle tissue, Laminin 211 is of membrane bound integrin, and
critical for cardiomyocyte function and heart
muscle development. activation of intracellular signal cascades.
The recombinant human iMatrix-211 is a
Proven to support functional cardiomyocytes and high-quality matrix for basic research and
skeletal muscle cells culture, AMSBIO iMatrix
Laminin-221 is a simple to use recombinant drug development and toxicity studies with
fragment that retains the full integrin-binding these critical cell types.
activity of Laminin-211.
For further information on iMatrix Laminin 211
The culture of iPSC derived heart and please visit http://www.amsbio.com/imatrix-
recombinant-laminin-e8-fragments.aspx or
muscle cells under feed-free conditions contact the company on +44-1235-828200 / +1-
requires the use of extracellular matrix 617-945-5033 / info@amsbio.com.
proteins as an anchor to promote
adherence and functionality. Laminin

Microbioz India, January 2020 10

Cover Story
Founded in 1987, AMS Biotechnology (AMSBIO)
is recognized today as a leading transatlantic
company contributing to the acceleration of
discovery through the provision of cutting-edge life
science technology, products and services for
research and development in the medical, nutrition,
cosmetics and energy industries. AMSBIO has in-
depth expertise in extracellular matrices to provide
elegant solutions for studying cell motility,
migration, invasion and proliferation. This
expertise in cell culture and the ECM allows
AMSBIO to partner with clients in tailoring cell
systems to enhance organoid and spheroid
screening outcomes using a variety of 3D culture
systems, including organ-on-a-chip microfluidics.
For drug discovery research, AMSBIO offers
assays, recombinant proteins and cell lines.
Drawing upon a huge and comprehensive
biorepository, AMSBIO is widely recognised as a
leading provider of high-quality tissue specimens
(including custom procurement) from both human
and animal tissues. The company provides unique
clinical grade products for stem cell and cell therapy
applications these include high quality solutions for
viral delivery (lentivirus, adenovirus and adeno-
associated virus) in addition to GMP
cryopreservation technology.
For further Information:
MEDIA: Dr Bill Bradbury
Primetek Solutions, tel. +44-208-546-0869 /
email info@primetek-solutions.com
TECHNICAL: Dr Phillip Pridham Field
AMSBIO, tel. +44-1235-828200 / email
info@amsbio.com
Microbioz India, January 2020 11
Research News

One dose of HPV vaccine may prevent

infection from cancer-causing virus, study
reveals
A new study revealed that one dose of the HPV vaccine may prevent
infection from the potential cancer-causing virus, according to research
published in JAMA Network Open from The University of Texas Health Science
Center at Houston (UTHealth).

According to the Centers for

Disease Control (CDC), 34,800 new
cancer diagnoses are linked to
human papillomavirus (HPV)
annually. The virus is thought to
account for more than 90% of all
cervical and anal cancers, more than
60% of all penile cancers, and
approximately 70% of all oral
cancers.
While results of the paper showed
that a single dose may be as effective
as the currently recommended two-
or three-dose series, it's too early for
people to rely on a single dose of the
vaccine for protection, according to
senior author Ashish A. Deshmukh, PhD, MPH, an
assistant professor at UTHealth School of Public HPV infections. Yet, current vaccinations rates are
Health. less than ideal – half of people in the U.S. are not
HPV vaccine coverage is less than 10% globally because of vaccinated against this common sexually
poor vaccine uptake rates in many resource-limited countries. transmitted infection.
Ensuring boys and girls receive their first dose is a big The current HPV vaccine dosing regimen can be cumbersome
challenge in several countries and a majority of adolescents are for people to understand. If one dose is proven effective in
not able to complete the recommended series due to a lack of trials, the vaccine regimen will be simplified. This will help
intensive infrastructure needed to administer two or three improve the coverage rate among adolescents that are currently
doses. If ongoing clinical trials provide evidence regarding below the Healthy People 2020 goal and possibly will also
sustained benefits of a one-dose regimen, then implications of increase the momentum of uptake in the newly approved age
single-dose strategy could be substantial for reducing the group."
burden of these cancers globally." Kalyani Sonawane, PhD, lead author, assistant professor at
Ashish A. Deshmukh, PhD, MPH, senior UTHealth School of Public Health
author, assistant professor at UTHealth School Source:
of Public Health University of Texas Health Science Center at
Although the study participants included only Houston
women, the CDC recommends a two-dose regimen Journal reference:
for all children starting the series before age 15 or a Sonawane, K., et al. (2019) Prevalence of Human
three-dose regimen if the series is started between Papillomavirus Infection by Number of Vaccine
ages 16 to 26. The latest generation of HPV vaccine Doses Among US Women. JAMA Network
can protect against nearly 90% of cancer-causing Open. doi.org/10.1001/jamanetworkopen.2019.185
71.

Microbioz India, January 2020 12

Research News

Proton therapy has similar cure rates,

fewer serious side effects compared with
traditional radiation
Cancer patients who receive high-tech proton across several cancer types -- including lung, brain,
therapy experience similar cure rates and fewer head and neck, gastrointestinal and gynecologic
serious side effects compared with those who cancers -- to show a reduced side-effect profile for
undergo traditional X-ray radiation therapy, proton therapy compared with X-ray radiation
according to a study led by Washington University therapy for patients receiving combined
School of Medicine in St. Louis and the Perelman chemotherapy and radiation. None of the
School of Medicine at the University of patients had metastatic cancer, in
Pennsylvania. which a tumor has spread to
The reduction in side effects -- particularly other parts of the body.
lower hospitalization The researchers
rates and fewer found no differences
emergency room visits between the two
-- could offset the groups in survival
higher initial cost of and cancer control,
proton therapy, which suggesting that proton
often is not covered by therapy is just as effective
private insurance in treating the cancer even as
because of its higher it caused fewer side effects.
upfront expense and Overall survival at one year
limited data on its for the
effectiveness proton
compared to X-ray therapy
radiation, according to group was
the researchers. 83 percent
The study is published versus 81
Dec. 26 in JAMA percent
Oncology. Some of the findings for the X-
also were presented in June at the American ray
Society of Clinical Oncology's annual meeting, in radiation
Chicago. therapy
We observed significantly fewer unplanned hospitalizations group. This difference tipped
in the proton therapy group, which suggests the treatment may slightly in favor of proton therapy but was not
be better for patients and, perhaps, less taxing on the health- statistically significant.
care system. If proton therapy can reduce hospitalizations, The difference in side effects was more
that has a real impact on improving quality of life for both pronounced. Forty-five of 391 patients receiving
our patients and their caregivers." proton therapy experienced a severe side effect in
Brian C. Baumann, MD, first author, assistant professor the 90-day time frame (11.5 percent). In the X-ray
of radiation oncology at Washington University and an radiation therapy group, 301 of 1,092 patients
adjunct assistant professor of radiation oncology at Penn experienced a severe side effect in the same period
While radiation therapy can be curative for certain (27.6 percent). The patients receiving proton
cancers, it also causes severe side effects -- such as therapy experienced fewer side effects despite the
difficulty swallowing, nausea and diarrhea -- that fact that they were, on average, older and had more
reduce quality of life and can, in some cases, require medical problems than those receiving standard X-
hospitalization, said Baumann, who treats patients ray radiation therapy. After taking steps to control
at Siteman Cancer Center at Barnes-Jewish Hospital for these differences, the researchers found that
and Washington University School of Medicine. patients receiving proton therapy experienced a
The study, which included almost 1,500 patients two-thirds reduction in the relative risk of severe
from Penn Medicine, is the first large review of data side effects within the first 90 days of treatment,

Microbioz India, January 2020 14

Research News
compared with patients receiving X-ray radiation
therapy.
Both types of radiation therapy are approved by the
Food and Drug Administration for cancer
treatment. X-ray beams are made up of photons,
which are electromagnetic particles that have
almost no mass, allowing them to travel all the way
through the body, passing through healthy tissue on
the way out. Protons are relatively heavy, positively
charged particles that hit their target and stop,
essentially eliminating the exit dose of radiation.
Since the study found proton therapy to have fewer
adverse events, Baumann said it could prompt
radiation oncologists to design clinical trials to
investigate whether increasing the dose of proton
radiation would help patients do better, while still
maintaining acceptable levels of side effects.
Similarly, the reduced side effects of proton therapy
could allow older patients with additional medical
conditions -- who are typically excluded from
clinical trials because of their frailty -- to participate
in trials investigating more intensive treatments that
could be beneficial.
"Clinical trials often are limited to patients who
have serious cancers but are otherwise quite
healthy, and that's not the real-world cancer
population," said Baumann. "Doctors, rightly, are
concerned about toxicity. But with the reduced
toxicity that we found with proton therapy, this
might open the doors to the possibility of older
patients with multiple medical problems getting
cancer therapy they can tolerate that is more likely
to be curative.
"With our aging population, this could have a big
impact on a lot of patients," he added. "To me,
that's an exciting implication of this research."
Source:
Washington University School of Medicine
Microbioz India, January 2020 15
Featured Article

Effectiveness of healing
with Beej Mantra
Beej Mantra is the shortest form followed diligently can make you free from

A
of a Mantra just like a Beej (seed) diabetes, BP, Thyroid etc.
which when sown grows into a
tree. When recited together these
About us:
Dr Arti & Dr Gaurav Shukla
Beej Mantras give humans lot of
Dr Arti Shukla: A PhD in psycho-sociology and is
positive energy. They are the
a depression expert, a dermatoglyphics expert, she
vibrations, and represent the
is a healer and an expert counselor.
"call" of the soul. It is a belief that
Dr Gaurav Shukla: Previously a MBA marketing
when the universe was created then the sounds
with 16 yrs of corporate exposure - a DGM in
produced during the cosmic evolution were
Videocon Telecom, Cadbury, Reliance, Airtel till he
basically the Beej mantras. After attaining
decided to move into a completely different field
knowledge of the Beej Mantras and understanding
and went on to do extensive research in Education,
its connections with Mind, Body & Soul, the
Diagnostics and Healing and got Masters & PhD in
individual can use subtle energy to heal physical and
Sanskrit. Both live in Mumbai. Together we are
psychological ailments. Today we are having
amongst the pioneers in the field of researching our
diseases / disorders primarily due to a sedentary
traditional wisdom practices and creating
lifestyle. From our traditional eastern knowledge &
meditative techniques and applications that can
understanding of the source code we have designed
bring about fast healing. We
a unique meditation program using Beej Mantras
This program aims at
reducing ill effects of
diseases connected
with stress like
Diabetes, BP,
Thyroid, obesity and
keeps you tranquil- a
key to stay healthy.
Diabetes occurs due
to imbalance in us, so
we have to bring
back homeostasis.
Mainly stress,
anxiety, fear, desire
for approval from
self and others, lack
of self love or love in
life. Increased stress
levels or hidden
stress start affecting the whole internal physical integrated behavior, with Beej Mantras and
system, including metabolism, hormone secretion conceived the comprehensive techniques designed
etc. causing the pancreas to get overburdened. This to cleanse and energize the physical body, mind &
disrupts its proper functioning and results in a rise Soul. This process accelerated the rate at which the
of the sugar level. By training to bring back the body can heal itself. Our training process is
homeostasis/balance through meditation Total designed in a manner that even new students can
Wellness Program can be helpful in managing most rapidly learn the techniques to heal simple ailments.
of the diseases. It is free from side effects and if

Microbioz India, January 2020 16

Featured Article
This enables them to produce immediate positive 3) Soulfulness Meditation
results that contribute to a life of good health and 4) Diet
well-being. 5) Healing
Dr. Tarini Vats, MD.: Adaptive medical graduate 6) Consultation
with proven experience with data entry and medical 7) Ayurvedic Supplements with Tissue salts
terminology. Experience with multiple fields of 8) Stress buster techniques
medicine. Multi-tasker, detail-oriented and team 9) Sandhi Marma stress points Knowledge
player with excellent interpersonal skills. sessions
Effectively communicates with medical personnel, Duration:
colleagues, and patients. 1) 45 Minutes
Dr. Neelam Vats: Certified CBT Practitioner 2) 5 Min Opening
(CBT), September, 2018, The Academy of Modern 3) 10 Min. of Intro to Concept, Chakra
Applied Psychology, San Francisco CA. assessment & Report
4) 20 Min of Labdhikagra Meditation
Our vision 5) 5 Min of Mass Pronunciation of
Vision is to put India onto the world map in Phonemes.
traditional wisdom practices of healing by 6) 5 Min Closing
leveraging past wisdom residing in our shastras,
devoid of superstitious beliefs and ancient End results:
unsubstantiated rituals. After more than a decade Activates all cells in the body, improves circulation
of research, we formulated new concepts and and increases
vital energy
flow, reduces
stress,
anxiety and
depression
Deep relaxation
and pain relief
Lowers anger
and blood
pressure
Cleanses
negative energy
and emotions
Balances both
hemispheres of
brain and
improves sleep
Stimulates,
balances and
purifies our
senses and
techniques - Beej Mantra Healing that helped chakras, and enhances aura removes blockages and
explain energy healing as a practical science. Our toxins, and gives you a healthy glow
endeavor is to systematize the world of energy
healing in to a comprehensive structured body of Promotes stillness, happiness and well being
knowledge. We have, in fact, demonstrated this in Strengthens immune system, soothes
one hour sessions with more than 150 people and harmonizes emotions & feelings, changes old
concurrently whose BP and Sugar readings showed unhealthy thought patterns & habits that no longer
a significantly lower value post the meditation. serve us deepens meditation and connection with
Program details: higher self.
1) Special Beej Mantra techniques
2) Breathing techniques

Microbioz India, January 2020 17

Business News
Indian Non-Profit YRGCARE Selects
NetSuite to Support its Mission to Save
More Live
NetSuite helps non-profit expand operations across India
and focus time, resources and expertise to support those
in need
YRGCARE, an Indian non-profit that provides
clinical care to individuals diagnosed with HIV and
other infectious diseases, has selected Oracle
NetSuite to support its mission to save more lives.
Through NetSuite’s Social Impact program,
YRGCARE has been able to focus its resources on
helping those in need and support a growing
number of patients across India by taking
advantage of unified platform to streamline
business processes and reduce operating
costs.Founded in 1993 by the late Dr Suniti
Solomon, a pioneer in India’s fight against HIV,
YRGCARE has supported more than 20,000
patients ranging from small children to pregnant
women and other infected adults. To bring its
clinical care, education and research to more people
and support expanded services for patients with
hepatitis C, tuberculosis, STDs and other infectious
diseases, YRGCARE has expanded from three
locations across India to 15. To support its growing
operations, which currently help approximately
4,000 people a year, and ensure all resources are
used as efficiently as possible to support its
mission, YRGCARE selected NetSuite.
“We are focused on the needs of those who are
not receiving care, support, education, and
information about HIV other infectious diseases,”
said Ganesh Aylur Kailasam, chief program officer
and research administrator, YRGCARE. “I joined
YRGCARE when we launched 25 years ago and as
we have grown to help more and more people, our
operations have become more complex. With
NetSuite we have been able to reduce that
complexity so we can ensure we can spend time and
resources on making a real difference in people’s
lives.” With NetSuite, YRGCARE has been able to
automate previously manual processes and enhance
visibility across its growing operations. NetSuite
has enabled YRGCARE to reduce the time taken
to close its financial processes from 45 days to 10
days and redeploy resources that were previously
dedicated to procurement and IT management to
focus on directly helping those in need. The
enhanced visibility into business operations has
enabled YRGCARE to track expenses on a per-
project basis and comply with reporting
requirements from donors, which includes several
U.S. government agencies, while also meeting
Indian government tax requirements.
“Nonprofits like YRGCARE do amazing and
incredibly difficult work and that requires complete
focus,” said Graeme Burt, VP & Chief Commercial
Officer, Oracle NetSuite JAPAC. “With NetSuite,
the YRGCARE team has been able to drive
efficiencies across their core business processes so
they can focus their time, resources and expertise
on reducing the spread of infectious diseases in
India. We have huge admiration for the
YRGCARE team and applaud their commitment
to the communities in which we live and work.”
As a nonprofit, YRGCARE is benefitting from
donated software through the Oracle NetSuite
Social Impact program. Through the Suite Pro
Bono part of the program, the organization is
receiving support, at no cost, from skilled NetSuite
employees to help them use the platform more
effectively.
About YRGCARE
YRGCARE, founded in 1993 in Chennai, India is
a premier HIV/AIDS service organization offering
services including: Adolescent and young adult
sexuality education, HIV intervention at
workplaces and communities, Voluntary
Microbioz India, January 2020 18
Business News
counselling and testing services, treatment for
sexually transmitted diseases, Care and support
services to over 20,000 People Living with
HIV/AIDS (PLHA), education and advocacy to
reduce violence against women and much more.
In partnership with leading centres from around
the world, YRGCARE is currently implementing
research in the fields of epidemiology, laboratory
sciences, prevention, implementation science and
treatment outcomes. It is among the few
institutions in Asia monitoring the emerging HIV
drug resistance.
For more information on how nonprofits and
social enterprises are leveraging Oracle NetSuite,
visit www.netsuite.com/socialimpact
About Oracle NetSuite
For more than 20 years, Oracle NetSuite has helped
organisations grow, scale and adapt to change.
NetSuite provides a suite of cloud-based
applications, which includes financials / Enterprise
Resource Planning (ERP), HR, professional
services automation and omnichannel commerce,
used by more than 18,000 customers in 203
countries and dependent territories. For more
information, please visit
https://www.netsuite.com/portal/in/
Follow NetSuite’s Cloud blog, Facebook page and
@NetSuiteJAPAC Twitter handle for real-time
updates.
About Oracle
The Oracle Cloud offers complete SaaS application
suites for ERP, HCM and CX, plus best-in-class
database Platform as a Service (PaaS) and
Infrastructure as a Service (IaaS) from data centers
throughout the Americas, Europe and Asia. For
more information about Oracle (NYSE:ORCL),
please visit us at www.oracle.com
Trademarks
Oracle and Java are registered trademarks of Oracle
and/or its affiliates. Other names may be
trademarks of their respective owners.
For further information, kindly contact:
Oracle NetSuite India
Monica Srivastava
Public Relations
+91 95990 45075
K2 Communications Pvt. Ltd.
Lavanya Venkatesh / Vellaichamy
+91 9902242957 / +91 9884552209
Interview
Dr Ryan M Nunley Shares His Experiences
with City Doctors on Technological Advancements
in Wound Closure Management in Joint
Replacement Procedures
A three-day training and knowledge sharing
program was flagged off in New Delhi on October
2, 2019 by Dr Ryan M Nunley, Associate Professor
from Washington University Orthopaedics in St.
Louis to educate and equip surgeons with the latest
technological advancements in the field of wound
closure management. As the incidence of surgical
site infections is relatively higher in India compared
to rest of the world, the 3-day program gave the
potential to highlight the benefits of latest
advancements in the space of wound closure,
especially in joint replacement procedures. The
training and knowledge sharing program was
planned to increase awareness about soft tissue
management with leading surgeons in India across
three cities – New Delhi, Hyderabad and Pune.
More than 50 Orthopedic surgeons across 3 cities
participated and were educated on the
technological advancements to improve the
treatment process to enable patients with faster
mobility, minimum scar, reduced infection, easier
self-care and ensure better quality of life. These
advanced systems will also provide minimally
invasive skin closure techniques that lead to greater
patient satisfaction and better cosmesis.
The primary aim of the educational initiative was to
highlight the effective use of safe and secure wound
closure, as it is critical to avoid the risk of Surgical
Site Infections (SSI), which can lead to re-
admission and ultimately resulting in higher costs
for the healthcare system. In Asia Pacific alone,
patients are up to 20 times more likely to acquire a
healthcare-associated infection with SSIs.
According to the World Health organization more
than 1 in 10 patients in low- and middle-income
countries will get a surgical site infection. A lack of
surveillance and implementation of global
guidelines continue to inhibit progress around SSI
prevention in Asia Pacific, taking the mortality rate
up to 46% in Asia Pacific countries.
Moreover, an SSI infection pertaining to
orthopedic surgical procedure can increase the
Dr Ryan M Nunley
patient’s hospitalization time by up to two weeks
and care costs by more than 300%. SSIs in
orthopedic procedures also present a stark and
catastrophic complication for patients, surgeons
and hospital institutions. The SSI range from low
to high for Total Knee Replacement (TKR) is
1.74% to 12.5%.
Speaking on this, Dr Ryan M Nunley further added,
“One of the biggest challenges with joint
replacement surgery across the world is infection.
It is one thing that we've not been able to eliminate.
Hence, adopting technologies which reduces risk of
infection is a key goal in all aspects of orthopedic
surgical procedures, especially Total Knee and
Total Hip Arthroplasty. With latest advancements
in wound closure management in joint replacement
surgeries, we can meet the changing customer
demands and provide better treatment to patients.
The last 3 days in India gave us this opportunity to
equip surgeons with information and share my
experiences with wound closure systems in
orthopedic surgeries which are less invasive, have
reduced incidence of drainage/hematoma/SSI,
provide watertight closure techniques, are easier to
remove by patients at the convenience of their own
home (less visits back to the clinic which can be
expensive and time consuming for the patient and
family members), dressings with significantly less
pain than staples (skin clips) and provide better
cosmesis.”
Microbioz India, January 2020 20
Interview

During orthopaedic surgeries, it is important to pay Minimizing risk of surgical site infections is
attention to the management of soft tissue as possible with attention to the wound both during
improper management can lead to pain, drainage, and post-surgery by surgeons as well as patients.
hematomas, infection, readmission or other For any medical procedure, improved patient
complications, which can be devastating to patient outcome and patient satisfaction is the key goal.
and the families. Attention to wound closure It is important to understand that in the case of
systems at the time of surgeries orthopedic surgeries, the challenges affecting
increases patient leading to dis-satisfaction include the
surgeon’s need for more clinic visits to remove staples
precision and or sutures, superficial infections, abscess
can positively formation, wound dehiscence, prolonged
impact wound discharge, readmission to the
patient’s hospital, and re-operation. Using wound
functional closure systems that reduce wound healing
recovery, complications that do not require manual
quality of removal by a physician or healthcare
life and provider as a solution will significantly
patient improve patient satisfaction and outcome,
satisfaction. as well as reduce the over cost the healthcare
It will reduce system.
the economic burden on healthcare system and re-
hospitalization rates.

Microbioz India, January 2020 22

Pre Event Coverage

India Health Exhibition launches to

facilitate growth in India’s US$372 bn
healthcare market
 India Health Exhibition will take place from 14-16 April 2020, in New Delhi,
brought to you by Arab Health organisers, Informa Markets
 India’s healthcare sector is set to increase three-fold to US$ 372 billion by 2022
 Introducing conferences that will focus on the country’s healthcare strategy
and developments

New Delhi, India, 25

November 2019: Informa
Markets, the largest
international exhibitions
organiser, are gearing up to
launch India Health
Exhibition from April 14-
16, 2020. This comes in
response to the global
industry’s desire to develop
business within one of the
world’s fastest growing
markets. The show will
host a unique combination
of a full-scale exhibition
along with a diverse range
of educational conferences
that are run in partnership
with leading local
associations.

With over 44 years of experience in hosting Arab
Health Exhibition and Congress, the largest
healthcare exhibition in the Middle East, along with
market leading shows such as Africa Health and
Florida International Medical Expo (FIME),
Informa’s events work on the tried and tested
methodology of providing topical, affordable and
high-quality education alongside a comprehensive
exhibition made up of the world’s latest innovators
in the medical space. Informa Group’s acquisition
of UBM further allows it to leverage on the
strength of the annual CPhI India event that brings
key players from India's pharma sector together.
Commenting on the launch of the show, Wouter
Molman, Executive Vice President Healthcare,
Informa Markets, said: “The show firmly brings
India Health into our family of global healthcare
exhibitions brands, which includes the trusted Arab
Health Exhibition and Congress. Recent reports
have highlighted that the growing demand for
quality healthcare and the absence of a matching
delivery mechanism pose a great challenge in India.
This launch event will allow us to facilitate business
interaction within the growing Indian healthcare
market and provide a springboard to growth
drivers.
“One of the other common challenges that
companies often face in the Indian healthcare
market is the lack of connection and relationships
with the right healthcare entities, authorities and
associations in India. India Health will help bridge
this gap.”

Microbioz India, January 2020 24

Pre Event Coverage
The three-day event will take place in New Delhi’s
Pragati Maidan and host 300 plus international and
local exhibitors from a variety of sectors ranging
from disposables and consumables through to
high-tech imaging and diagnostic equipment. The
show will welcome 4,000 plus key decision makers
and stakeholders right from hospital directors,
doctors, medical practitioners, government
policymakers, medical laboratory technicians,
distributors and traders.
The event’s three CME-accredited conferences
have been curated around the country’s healthcare
strategy to explore the challenges it faces, and the
innovation required to overcome them. These will
be held in collaboration with notable associations,
including Association of Healthcare Providers
(India), Healthcare Federation of India and more.
Explore opportunities created by a billion-
dollar market
As the second most populous country in the world,
India has become one of the fastest growing
healthcare markets globally, both in terms of
revenue and employment.
The country’s healthcare market is all set to
increase three-fold to US$ 372 billion by 2022.
India is expected to rank amongst the top three
healthcare markets in terms of incremental growth.
The country will generate 40 million jobs by 2020.
Projections are that US$ 200 billion will be spent
on medical infrastructure by 2024.
The medical device market is expected to reach
US$ 11 billion by 2022.
India has emerged as a hub for R&D activities for
international players due to the relatively low cost
of clinical research.
India imports nearly 80 per cent of its medical
devices.
The cost of surgery in India is about one-tenth of
that in the U.S. This has helped in attracting
medical tourists and the value of India’s medical
tourism industry is forecasted to reach US$ 9 billion
by 2020.
India Health will put the spotlight on all these
developments and facilitate conversations that will
allow these strategies to be brought to life. The
show will attract international participation and
offer access to those who haven’t been able to enter
this vast market yet.
Yogesh Mudras, Managing Director, Informa
Markets India, highlighted: “India’s healthcare
sector at present is growing at 15.8 per cent
Compound Annual Growth Rate (CAGR) for a
plethora of reasons. India Health will bring
together the key players in the global market to
meet and do business with the Indian healthcare
sector and to capitalise on this growth.
“A significant percentage of purchasers of medical
devices are private medical institutions and
hospitals. Due to increased competition in Tier I
cities, private enterprises have started to focus on
Tier II and Tier III cities, a market which is until
now untapped in India. As private enterprises
expand in lesser explored markets, the demand for
medical devices will expand proportionally, and
India Health will help the industry tap that
potential.”
With exciting opportunities in store for R&D,
medical tourism and investment in healthcare
infrastructure developments, attending India
Health is essential in order to understand and
operate in one of the world’s largest healthcare
markets.
For more information visit www.indiahealth-
exhibtion.com
More about Informa Markets:
Informa Markets – Healthcare Group, organises 15
exhibitions and 110 conferences yearly covering the
Middle East, Africa, Asia, Europe and US market,
connecting more than 720,000 healthcare professionals
worldwide and offering a range of marketing solutions
for companies involved with the healthcare sector. Over
100 congresses take place in parallel with the exhibitions.
Informa Markets have a number of digital and print
offerings, publishing a variety of healthcare magazines
and medical directories, with a readership of top
decision-makers in the MENA region’s healthcare
industry. Additionally, Omnia Health, their global
medical directory, is a unique digital platform providing
company and product information 365 days of the year,
allowing users to connect with exhibitors and products
in one simple click of a button.
https://informa.com/divisions/informa-markets/
Microbioz India, January 2020 26
Product Launches

Zeiss Introduces
Four Axiocam
Models for Light
Microscopy
Applications
All four of the newest Axiocom microscope
cameras utilize high-quality CMOS sensors to
Zeiss, Oberkochen, Germany, has introduced four
deliver a combination of excellent contrast,
new high-quality complementary metal oxide
resolution, dynamic range, sensitivity, and readout
semiconductor (CMOS) cameras to support digital
speed. Small 3.45 µm pixels and low noise levels, in
imaging in light microscopy. The cameras complete
combination with the fast USB 3.0 platform, enable
the portfolio of Zeiss Axiocam models:
researchers to carry out extremely fast imaging
The Axiocam 705 color and 712 color deliver the
experiments while maintaining excellent signal
best possible image quality for histology, pathology,
quality. Also, the new cameras’ global shutter
or materials research and analysis, thanks to
architecture allows the capture of dynamic samples
excellent color rendition and greatly improved
without motion artifacts.
Story source/Credit: Zeiss.

FDA Clears
Lumipulse G Whole
PTH Assay
dynamic range.
The Axiocam 705 mono and 712 mono are ideal
for demanding fluorescence live-cell imaging, with
fast frame rates and high dynamic range. Also, their
extended near-infrared sensitivity allows for deeper
insights into sample structures.
The Axiocam 705 mono and Axiocam
705 color are five-megapixel cameras
optimized for fast speed and high
dynamic range. The Axiocam 712 mono
and Axiocam 712 color are 12-megapixel
cameras that are especially suited for the
acquisition of large samples, with greatly Fujirebio Diagnostics, Malvern, Pa, has received
FDA clearance for use of its new Lumipulse G
reduced need for image stitching. whole PTH assay on the company’s Lumipulse
G1200 immunoassay platform.
Parathyroid hormone (PTH) is secreted by the four
small parathyroid glands, which are located behind
the thyroid. PTH regulates the metabolism of
calcium and phosphoric acid in the body. The
measurement of whole PTH (or PTH 1-84) using
the Lumipulse G whole PTH assay can be used in

Microbioz India, January 2020 28

Product Launches

the differential diagnosis of hypercalcemia and

hypocalcemia resulting from calcium metabolism
disorders.
VRNxT Technology
The Lumipulse G whole PTH assay has a
significant benefit over prior generation intact PTH
(iPTH) assays because the ability to measure
Automates Sample
biologically active PTH helps to understand
parathyroid function without potential
Volume Reduction
misclassification of the patients. There is no
detectable cross-reactivity to PTH 7-84 or other
PTH fragments that may be seen with iPTH assays;
the whole PTH assay measures only biologically
active PTH and is 100% specific. Intact PTH can
overestimate PTH-indicated bone or mineral
abnormalities because iPTH assays also detect
various PTH fragments.1
Clinical practice guidelines for chronic kidney
disease and mineral and bone disorder recommend
the measurement and monitoring of several tests,
including PTH, for chronic kidney disease patients
not yet on dialysis. A falsely high PTH
measurement due to a second-generation iPTH test
could result in falsely identifying a patient for
dialysis. The Lumipule G whole PTH assay is also Menarini Silicon Biosystems, Bologna, Italy, and
traceable to in-house calibrators that have been Huntingdon Valley, Pa., has launched its new
assigned to the World Health Organization VRNxT sample volume reduction instrument.
standard (UK National Institute for Biological By standardizing sample volume reduction, the
Standards and Control 95/646), while iPTH assays VRNxT instrument adds precision and accuracy to
are not standardized and their values can vary by rare-cell and single-cell analysis, minimizing the loss
manufacturer. of precious samples and increasing workflow
The Lumipulse G whole PTH assay on the throughput. While the VRNxT instrument has
Lumipulse G1200 analyzer offers a fully automated been developed to standardize workflows for the
assay with a reaction time of just 30 minutes, using company’s DEPArray single-cell analysis system,
a single test cartridge design for reagent stability, broader applications in volume reduction are
efficiency, and testing flexibility. The assay has possible.
demonstrated excellent precision with a coefficient
of variance ≤4.0%.
“The Lumipulse G whole PTH assay is an
innovative next-generation assay to help diagnose
calcium metabolism disorders, and to help monitor
and adjust treatment of CKD patients,” says
Matthew Bell, vice president of sales and marketing
at Fujirebio US.
Story source/Credit: Fujirebio Diagnostics.
Reference Fabio Piazzalunga, Menarini Silicon Biosystems.
Kazama JJ, Omori K, Higuchi N, et al. Intact PTH “The VRNxT was created in direct response to
assay overestimates true 1-84 PTH levels after customer feedback to help streamline, automate,
maxacalcitol therapy in dialysis patients with and standardize rare-cell analysis workflows,” says
secondary hyperparathyroidism. Nephrol Dial Fabio Piazzalunga, CEO of Menarini Silicon
Transplant. 2004;19(4):892–897. Biosystems.
The VRNxT automated volume reduction
instrument removes manual pipetting steps,
reducing hands-on time up to 90% and eliminating
operator variability. No specific skill sets or training

Microbioz India, January 2020 30

Product Launches
are required to operate the instrument, thereby
delivering user-independent results with high
reproducibility and success, with 99% of single cells
retained after volume reduction.
Matija Snuderl, MD, NYU Langone Health.
“The instrument helped us to reduce our error rate
and processing time,” says Matija Snuderl, MD,
associate professor of pathology and director of
molecular pathology at NYU Langone Health, who
tested the new instrument in his laboratory. “We
handle rare cell types isolated from FFPE
specimens. With the VRNxT, we were able to
lower the chance of error in the volume reduction
step, which is especially important when single-cell
samples are collected, and decrease the time
required to process these samples.”
The VRNxT uses rotational motion for sample
volume reduction and can process up to four
samples at once, decreasing the time required for
sample preparation and consistently reducing
sample volume to approximately 12.5 μL in 25
seconds. Downstream of analysis via the
DEPArray system, VRNxT reduces volume to
approximately 2 μL in about 8 seconds, making the
samples ready for whole-genome amplification.
Story source/Credit: Menarini Silicon Biosystems.
Quantitative Assay
Applications
Simplify Detection-
Based Assays
Quantitative Assay applications from BioTek
Instruments, Winsooki, Vt, offer convenience and
simplicity to researchers performing fluorescence-
based DNA assays or commonly used detection-
based assays for quantifying protein concentrations
in a sample, including absorbance-based
bicinchoninic acid assays, Bradford protein assays,
and Lowry protein assays. The apps are powered
through BioTek’s Gen5 data analysis software and
are compatible with the company’s microplate
readers equipped with the relevant detection mode,
including the Cytation and Synergy multimode
readers.
User-friendly features include predefined protocols
with simple step-by-step setup, along with quick
plate map definition and easy data export. After
detection, the Quantitative Assay applications
perform automatic curve fitting as well as
concentration normalization and target volume
calculations.
Story source/Credit: BioTek Instruments.
Elysium Health
Launches Tool to
Determine Biological
Age of Individuals
Microbioz India, January 2020 32
Product Launches
Elysium Health, New York City, has launched
Index, an at-home test intended to enable
individuals to measure their cumulative rate of
aging and determine their biological age.
Aging researcher Morgan Levine, PhD, associate
professor of pathology at the Yale School of
Medicine, has joined Elysium Health as head of
bioinformatics to lead the development of Index
using the latest generation of an epigenetic
biomarker called DNAm PhenoAge.
Unlike earlier epigenetic clocks, which were
developed to support population-level research,
Index was developed by Levine and the Elysium
Health team to further improve the testing
methodology and make its application accurate and
informative at the individual level.
“Scientists in the field of aging research have long
explored two fundamental questions: can aging
itself be measured; and can we slow, stop, or
reverse the processes associated with aging?” says
Eric Marcotulli, CEO of Elysium Health. “With
aging as the single greatest risk factor for all major
chronic conditions—and a force that affects
everyone even before birth—these questions are
focused on supporting our collective ability to not
only improve lifespan but, more importantly,
‘healthspan.’
“With the launch of Index, we hope to continue the
scientific exploration of these two questions by
extending the conversation to the consumer market
and allowing everyone to benefit from the ability to
determine their cumulative rate of aging and, with
it, to see if lifestyle and other changes can impact
how they age in the future,” adds Marcotulli.
Levine helped to identify specific DNA
methylation sites along the epigenome that are
highly correlated with nine known clinical
chemistry biomarkers of biological age and
chronological age. Since the development of the
first epigenetic clock in 2011, the methodology has
been further refined and validated in multiple large-
scale datasets across diverse populations and
tissues.
A challenge to developing Index—and a key
differentiator—was ensuring its accuracy and
repeatability at the individual level. While the
published applications of the biological age
measure typically look at hundreds of sites on the
genome, Index examines global patterns across
more than 100,000 sites, which solves for issues
related to technical replicates—an important
consideration for making the technology available
to consumers and researchers.
“Historically, chronological age has served as the
best estimation of health and aging. However, not
all individuals age at the same rate—based on
genetics, demographics, and lifestyle factors—and
therefore, people of the same chronological age
don’t necessarily share the same current health
status or future outlook,” says Levine. “Index
provides a better picture of where an individual is
in his or her aging process, which is why I’m excited
to make this aging measure and the technology that
supports it directly available to consumers. It shows
incredible promise when it comes to monitoring
overall health and wellness, and there is potential
for even more diverse applications in the future.
“In clinical research, tools like this also enable
faster evaluation of intervention efficacy, avoiding
the need for decades of follow-up,” Levine adds.
“It may also inform basic and population research,
by shedding light on factors that alter the pace of
aging and facilitating the identification of
therapeutic targets to slow the process. For people
in their everyday lives, while there are no
guarantees, understanding one’s cumulative rate of
aging and the factors that are reflected on the
epigenome may help them prioritize behaviors and
lifestyle choices to proactively optimize their health
and wellness today and in the future.”
While the technology required for epigenome and
genome mapping has historically made
comprehensive testing cost-prohibitive, Elysium
Health enlisted the help of Illumina, San Diego, to
develop the custom Elysium chip to make the
initial release of Index as accessible as possible.
Elysium Health is committed to continuing to
innovate the testing technology to make its measure
of biological age available to everyone.
Story source and Credit: Elysium Health
Advanced Technology
Simplifies Purification
of Nucleic Acids
Microbioz India, January 2020 34
Product Launches
Purigen Biosystems, Pleasanton, Calif, has
launched its ionic purification system, a small
benchtop unit that utilizes the company’s core
isotachophoresis technology to extract, purify, and
concentrate nucleic acids from biological samples
in 1 hour, with less than 3 minutes of hands-on
time per sample.

Barney Saunders, PhD, Purigen.

“The new ionic purification system will
fundamentally change how nucleic acids are
purified from precious samples prior to
downstream analysis using NGS and PCR,” says
Barney Saunders, PhD, CEO of Purigen. “When
The ionic purification system from Purigen Biosystems.
working with challenging sample types such as
The ionic purification system enables the
FFPE, or with small tissue samples, the ability to
automated extraction of nucleic acids with
dramatically increased yields and improved purity purify nucleic acids with maximal yield and quality
is crucial. More abundant and higher-quality nucleic
from a wide range of sample types, including
acids allow for superior quality data, which
cultured or sorted cells and formalin-fixed,
provides researchers with improved biological
paraffin-embedded (FFPE) tissues. Biological
samples are gently lysed and then loaded into the insights and empowers clinicians with more
actionable information.”
ionic fluidics chip. The ionic system then applies an
Story source/Credit: Purigen
electric field to the chip and the nucleic acids are
isolated in their natural, native form using the
company’s proprietary technology. The nucleic
Nona Scientific
acids are not denatured or dehydrated, and there is
no binding or stripping from fixed surfaces. The Introduces
process minimizes fragmentation and eliminates
any bead or buffer contamination. The extracted
nucleic acids are pure, abundant, and ready for
Technology That
analysis by any downstream technique, including
next-generation sequencing (NGS) or polymerase
Detects Synthetic
chain reaction (PCR).
Components of the ionic purification system Urine
include the ionic purification instrument, a small
benchtop system driven by a simple touchscreen
interface that can process one fluidics chip with
eight samples in approximately 1 hour; the ionic
FFPE to pure DNA kit, including six chips and a
reagent set with all the enzymes and buffers needed
to perform DNA extraction directly from as many
as 48 FFPE scrolls or slides; and the ionic cells to
pure DNA kit, including six chips and a reagent set
with all the enzymes and buffers needed to perform
cell lysis and DNA extraction from cultured or
sorted cells in up to 48 samples.

Microbioz India, January 2020 36

Product Launches
Reference laboratory Nona Scientific, Ocala, Fla,
has released its Synthetic Urine Detection test, a
new technology that can detect both synthetic and
adulterated urine, including 18 classes of
subversion and adulteration.
The laboratory’s goal for its cutting-edge
technology is to help stop Florida’s spiraling opioid
epidemic and save lives. According to the Centers
for Disease Control and Prevention, opioid
overdoses kill close to 200 people daily in the
United States. Moreover, the President’s Council of
Economic Advisers estimates that the cost of the
opioid crisis was $696 billion in 2018—
3.4% of the US
gross domestic
product—
and more than $2.5 trillion for the 4-year period
from 2015 to 2018.
“We are tired of everyone talking about the opioid
epidemic but not using our technology to stop the
epidemic in its tracks,” says Mike Palmer, CEO of
Nona Scientific. “Awareness is crucial, but it is time
to deploy breakthrough technology to save lives
and help heal our communities and state. If
someone has an addiction problem and they can
pass a drug test 10 out of 10 times while abusing
opioids, how can we get them help?”
Nona Scientific is also releasing an oral mouthwash
saliva drug test that detects more than 100 different
drugs. This technology will be important not only
for ‘shy bladder’ patients, but also in in rehab
settings, law enforcement, and workplaces.
Story source and credit: Nona Scientific.
Featured image: Urine samples ready for study.
Photo © Tatiana Belova, courtesy Dreamstime
(ID 134698681).
Philips India organizes knowledge sharing and
learning workshop ‘TechnoConnect’ in Delhi
Delhi, India – Royal Philips (NYSE: PHG, AEX:
PHIA), a global leader in health technology today
conducted its knowledge sharing and learning
workshop ‘TechnoConnect’ in New Delhi. The
initiative is aimed at familiarizing hospitals, nursing
homes and clinics in the country with the latest
advancements in healthcare as well as sharing
knowledge on best industry practices. This year
[1]
Philips introduces Technology Maximizer to boost
imaging equipment performance and clinical
capabilities, and help manage security risk
‘TechnoConnect’ has also been organized in
markets including Mumbai, Cochin and Dhaka
with overwhelming response.
Targeted across key metros in India, Philips’
‘TechnoConnect’ comprises an in-house
biomedical workshop for all Philips imaging and
patient care equipment and activities. It is focused
on highlighting expertise of biomedical engineers
and healthcare technology professionals. This is
first of its kind initiative to bring the biomedical
fraternity together, recognize their innovations and
give them a platform to share their thoughts to
bring collective improvement to their daily
practices.
The program will benefit health care staff across
the country to enhance performance in operational
theatres.
Commenting on the initiative, Rohit Sathe,
Vice President, Philips Health Systems, Indian
Subcontinent said “Aligned with Philips’ customer-
centric approach, we are glad to introduce TechnoConnect
programme in India. This comprehensive training and
learning suite of services will empower our customers across
the country to support both operational excellence and deliver
connected, predictive and personalized care.”
The initiative also introduced Technology
Maximizer, a cross-modality solution designed to
boost the clinical capabilities and performance of
imaging equipment through proactive and
structured upgrades. The service provides relief and
confidence to radiology and cardiology department
leaders as well as clinicians that their systems are up
to date and compliant at a fraction of the cost of
individual upgrades.
With Philips’ Technology Maximizer, healthcare
organizations no longer need to upgrade systems or
software on an individual basis. Through regular
upgrades and by refreshing existing hardware, this
five-year subscription program provides radiology
and cardiology departments with the latest software
and hardware updates while maintaining cost
efficiency through a predictable fee. Technology
Maximizer is available for selected Philips MR, CT,
IGT and Ultrasound systems, and runs in tandem
with existing RightFit Customer Service
Agreements[1].
Microbioz India, January 2020 38
Product Launches
TechnoConnect in Delhi saw a presence of 270+
healthcare fraternity representatives from 100+
healthcare institutions spread across the northern
region of India and Nepal. Dr. Vidur Mahajan–
Associate Director, Mahajan Imaging Pvt. Ltd. and
Head of R&D, CARING, shared his thoughts on
the role of artificial intelligence in healthcare.
The session also hosted several eminent speakers
from the healthcare industry who talked about
various issues including current trends in
healthcare, future of healthcare technology, and
addressed questions from the curious participants.
The professionals discussed on the optimum usage,
equipment safety and maintenance of Philips’
Radiology, Cardiology and various critical care
solutions. The program also showcased Philips’
latest range
of
innovative healthcare solutions such as
Compressed SENSE, Ambition 1.5T MR, Zenition
series, DigitalDiagnost C90, EPIQ Ultrasound
series and therapeutic care solutions.
By providing advanced, well-maintained medical
technology solutions and services, Philips aims to
improve health outcomes for people in India,
enhancing the patient experience, improving staff
satisfaction, reducing stress among care providers,
and lowering the cost of care.
For further information, please contact:
Philips India Corporate Communications
Geetika Bangia
M: +91 9818102133
E-mail: geetika.bangia@philips.com
AvianWE
Arshiya Ahmad
M: +91 83779 84933
E-mail: arshiya@avianwe.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a
leading health technology company focused on
improving people's health and enabling better
outcomes across the health continuum from
healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages
advanced technology and deep clinical and
consumer insights to deliver integrated solutions.
Headquartered in the Netherlands, the company is
a leader in diagnostic imaging, image-guided
therapy, patient monitoring and health informatics,
as well as in consumer health and home care.
Philips' health technology portfolio generated 2018
sales of EUR 18.1 billion and employs
approximately 80,000 employees with sales and
services in more than 100 countries. News about
Philips can be found at
http://www.philips.com/newscenter.
Microbioz India, January 2020 40
 PUBLISHED ON: 1st January 2020 RNI NUMBER: UPENG/2017/73675